How People Voted
50% For, 50% Against
0 votes cast
Take Action
 |
Alert Your Friends and Colleagues |
 |
Write Your Representative in Congress |
| Organize | |
|
Start A Petition |
| Save & Share | |
 |
del.icio.us |
 |
Digg |
 |
|
 |
|
 |
|
 |
Yahoo! |
H.R. 4332, The Generic Drug Application Review Fairness Act of 2012
- This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
H.R. 4332 would amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period.
()
Learn More
RSS Feeds for This Bill
Keep yourself updated on user contributions and debates about this bill! (Learn more about RSS.)
Visitor Comments
There are currently no comments for this bill